/Companies

Cypris Medical

Chicago, US · Founded 2016 · Delaware corporation

Find your way into Cypris Medical

Sign up to see every warm intro you have to Cypris Medical

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Cypris Medical team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Cypris Medical develops minimally-invasive medical devices and treatments designed specifically for plastic surgeons to deliver results comparable to traditional surgery with shorter recovery times. The company combines medical device expertise with input from practicing surgeons to address unmet needs in the plastic surgery market.

Founders & leadership

DHDan Holton
Dan HoltonPresident & CEODan Holton spent three decades in regulated healthcare across roles at Abbott, Hospira, and PartsSource, including building enterprise product development systems and leading marketplace platform initiatives. As founder and CEO of Cypris Medical, he advanced a surgical device through FDA clearance and established a partnership with Allergan.
C
ChrisProduct Development

Board

RH
Roger HoltonBoard director
LB
Louis BuckyBoard director
L
LouHead of Medical Advisory Board
GS
Grant StevensBoard director

Reported raises · per SEC filings

Form D private placements

$1.7M disclosed across 3 rounds · 2016–2020

▶$150KraisedJun 2020 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel HoltonExecutive Officer, Director
  • Louis BuckyDirector
  • Roger HoltonDirector
  • Grant StevensDirector
  • Christopher GodekDirector
Offering amount
$150K
Amount sold
$150K
Minimum investment
$1
First sale
Jun 2020
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$817.3KraisedFeb 2019 · 25 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel HoltonExecutive Officer, Director
  • Christopher GodekDirector
  • Louis BuckyDirector
  • Roger HoltonDirector
Offering amount
$1.1M
Amount sold
$817.3K
Minimum investment
$1
First sale
Feb 2018
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$755KraisedSep 2017 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel HoltonExecutive Officer, Director
  • Roger HoltonDirector
  • Louis BuckyDirector
Amount sold
$755K
Minimum investment
$1
First sale
Mar 2016
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 6

Companies working in the same space as Cypris Medical.

Frequently asked questions

What does Cypris Medical do?
Cypris Medical develops minimally-invasive medical devices and treatments designed specifically for plastic surgeons to deliver results comparable to traditional surgery with shorter recovery times. The company combines medical device expertise with input from practicing surgeons to address unmet needs in the plastic surgery market.
How much funding has Cypris Medical raised?
Cypris Medical has disclosed $1.7M raised across 3 rounds.
Where is Cypris Medical headquartered?
Cypris Medical is headquartered in Chicago, US.